000 | 01973 a2200529 4500 | ||
---|---|---|---|
005 | 20250513220553.0 | ||
264 | 0 | _c20001012 | |
008 | 200010s 0 0 eng d | ||
022 | _a0085-2538 | ||
024 | 7 |
_a10.1046/j.1523-1755.2000.00265.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIshikawa, Y | |
245 | 0 | 0 |
_aAnti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. _h[electronic resource] |
260 |
_bKidney international _cSep 2000 |
||
300 |
_a1078-87 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aFlavonoids _xpharmacology |
650 | 0 | 4 | _aGene Expression Regulation, Enzymologic |
650 | 0 | 4 |
_aGlomerular Mesangium _xcytology |
650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aJNK Mitogen-Activated Protein Kinases |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMutagenesis _xphysiology |
650 | 0 | 4 |
_aOxidants _xpharmacology |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-jun _xgenetics |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 |
_aQuercetin _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 | _ap38 Mitogen-Activated Protein Kinases |
700 | 1 | _aKitamura, M | |
773 | 0 |
_tKidney international _gvol. 58 _gno. 3 _gp. 1078-87 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1523-1755.2000.00265.x _zAvailable from publisher's website |
999 |
_c10920113 _d10920113 |